These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10912097)

  • 1. [In AT-III deficiency: heparin or hirudin?].
    Spannagel U
    MMW Fortschr Med; 1999 Oct; 141(42):14. PubMed ID: 10912097
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
    Levy JH
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
    [No Abstract]   [Full Text] [Related]  

  • 3. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 4. [Refludan: pharmacologic surveillance study].
    Winicki J
    Presse Med; 1998 Jun; 27 Suppl 2():31-2. PubMed ID: 9765664
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA panel votes against approval for bivalirudin.
    Piña I
    Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
    [No Abstract]   [Full Text] [Related]  

  • 7. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
    Roe MT; Granger CB; Puma JA; Hellkamp AS; Hochman JS; Ohman EM; White HD; Van de Werf F; Armstrong PW; Ellis SG; Califf RM; Topol EJ
    Am J Cardiol; 2001 Dec; 88(12):1403-6, A6. PubMed ID: 11741559
    [No Abstract]   [Full Text] [Related]  

  • 9. Re-exposure to recombinant (r)-hirudin in antihirudin antibody-positive patients with a history of heparin-induced thrombocytopenia.
    Harenberg J; Huhle G; Wang LC; Hoffmann U; Song XH
    Br J Haematol; 2000 May; 109(2):360-3. PubMed ID: 10848825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirudin and thrombosis prophylaxis.
    Turpie AG
    Lancet; 1996 Mar; 347(9002):632-3. PubMed ID: 8596373
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of recombinant hirudin in patients with heparin-induced thrombocytopenia with thrombosis requiring cardiopulmonary bypass.
    Latham P; Revelis AF; Joshi GP; DiMaio JM; Jessen ME
    Anesthesiology; 2000 Jan; 92(1):263-6. PubMed ID: 10638925
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia with thromboembolic arterial occlusion treated with recombinant hirudin.
    Schmidt OH; Lang W
    N Engl J Med; 1997 Nov; 337(19):1389. PubMed ID: 9380091
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of an acute flush reaction caused by subcutaneous r-hirudin with pegylated hirudin.
    Harenberg J; Hoffmann U; Huhle G; Song XH; Wang LC
    Br J Haematol; 2000 Mar; 108(3):528-30. PubMed ID: 10759710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute and relative truth in clinical trials.
    Julian D
    Lancet; 2002 Jun; 359(9321):1945-6; author reply 1946. PubMed ID: 12057577
    [No Abstract]   [Full Text] [Related]  

  • 15. Hirudin CGP 39393 as thromboprophylaxis.
    Williams DJ; Mahomed A
    Lancet; 1996 Jun; 347(9014):1561-2. PubMed ID: 8684139
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessening the punch of heparin-induced thrombocytopenia.
    Maloney JP
    Chest; 2002 Jul; 122(1):5-6. PubMed ID: 12114329
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy for patients with heparin-induced thrombocytopenia marketed.
    Am J Health Syst Pharm; 1998 Jul; 55(14):1444. PubMed ID: 9676284
    [No Abstract]   [Full Text] [Related]  

  • 19. Publication policy, informed consent, and the randomized clinical trial.
    Califf RM
    Am Heart J; 2002 Feb; 143(2):187-8. PubMed ID: 11835017
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R; Glässl A; Landthaler M; Stolz W
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.